PathogenDx Launches Novel D3 Array Multiplexed Molecular Diagnostics Technology for Urinary Tract Infection (UTI) Pathogen Detection and Antibiotic Resistance
Scottsdale, Arizona--(Newsfile Corp. - February 7, 2024) - PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of D3 Array™-UTI, a differentiated multiplexed PCR test that detects 26 pathogens and 12 antibiotic resistance gene markers to aid clinicians in delivering rapid UTI treatment. Powered by the Company's novel multiplexed molecular diagnostics technology, D3 Array™-UTI features testing in triplicate for quality assurance,...
2024-02-07 8:00 AM EST
PathogenDx Launches the Cannabis Industry's First AOAC Certified Rapid Semi-Quantification Test for Total Yeast and Mold with Results in a Single-Shift
Scottsdale, Arizona--(Newsfile Corp. - October 11, 2023) - PathogenDx (PathogenDx or Company), a leader in next-generation microarray technology for better health and safety, announced the launch of its new and improved rapid semi-quantification assay, QuantX Fungal, which has received an AOAC® Performance Tested Methods (PTM) SM Certificate to semi-quantify fungal species in total yeast and mold (TYM) for cannabis flower. Quantx Fungal joins the Company's comprehensive suite of cannabis...
2023-10-11 8:30 AM EDT
PathogenDx Enables Labs to Meet Cannabis Testing Regulations in Every State With Launch of Rapid Bacterial Semi-Quantification Four-in-One Test
Scottsdale, Arizona--(Newsfile Corp. - August 15, 2023) - PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of QuantX Bacterial, a new rapid bacterial semi-quantification four-in-one assay that enables cannabis testing labs to efficiently meet any state's microbial testing regulations. The QuantX Bacterial assay simplifies a lab's workflow, streamlines compliance reporting and improves labor efficiency while also delivering...
2023-08-15 8:00 AM EDT
PathogenDx's New Rapid, Single Test Detects Salmonella and 13 Serotypes in Poultry as Foodborne Illness Remains a Significant Threat to Public Health in the US
Scottsdale, Arizona--(Newsfile Corp. - July 13, 2023) - At a time when foodborne illness remains a significant threat to public health in the US, PathogenDx, a leader in next-generation microarray technology for better health and safety, announced the launch of SeroX, a new rapid, single test that detects Salmonella and 13 serotypes in a single shift to support the food industry's poultry sector. "Salmonella outbreaks are a huge issue fac
2023-07-13 7:00 AM EDT
PathogenDx Expands Reach of Its Patented Multiplexed Molecular Testing Technology, Bringing It to the Clinical, Food and Agriculture Sectors
Scottsdale, Arizona--(Newsfile Corp. - April 12, 2023) - PathogenDx ("PathogenDx" or "Company"), a leader in next-generation microarray technology for better health and safety, announced it has expanded the reach of its patented multiplexed molecular testing technology - Dynamic Dimensional Detection ("D3 Array™") - beyond the cannabis and hemp sectors. The Company is bringing its D3 Array™, which addresses the challenges microarray technology has suffered in prior generations as well as the...
2023-04-12 11:00 AM EDT
With a Two-Year Revenue Growth of 276%, PathogenDx Ranks No. 50 on Inc. Magazine's List of the Southwest Region's Fastest-Growing Private Companies
Scottsdale, Arizona--(Newsfile Corp. - February 28, 2023) - Inc. magazine revealed that PathogenDx ("PathogenDx" or "Company"), a leader in next-generation microarray technology for better health and safety, is No. 50 on its fourth annual Inc. 5000 Regionals Southwest list1, the most prestigious ranking of the fastest-growing private companies based in Arizona, New Mexico, Oklahoma, and Texas. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most...
2023-02-28 7:00 AM EST
PathogenDx Debuts Octa(TM) AutoPrep Station: a Simple, Easy-To-Use Automated Sample Prep Solution for the Cannabis and Hemp Testing Sector
AutoPrep Station to Launch in the Food and Environmental Testing Sectors Next YearScottsdale, Arizona--(Newsfile Corp. - November 14, 2022) - PathogenDx, a leader in next-generation microarray technology for better health and safety, launched Octa™ AutoPrep Station, an ultra-simple and easy-to-use automated sample preparation system for bacterial and fungal pathogen testing in the cannabis and hemp sectors. Octa™ AutoPrep...
2022-11-14 7:30 AM EST
PathogenDx Unveils Phytox: A New Breakthrough Virus Detection Technology to Curb the Spread of Plant-Born Pathogens in the Cannabis, Food and Agriculture Sectors
Scottsdale, Arizona--(Newsfile Corp. - September 15, 2022) - PathogenDx ("PathogenDx" or "Company"), a leader in next-generation microarray technology for better health and safety, launched a new breakthrough virus detection technology - Phytox - to help curb the spread of new and existing plant-born pathogens, which are currently on the rise. The new Asymmetric RT-PCR microarray technology for the cannabis, food and agriculture sectors is capable of detecting nine viruses or more in a single...
2022-09-15 7:30 AM EDT
PathogenDx Inc. Honored on the 2022 Inc. 5000 Annual List
Scottsdale, Arizona--(Newsfile Corp. - August 16, 2022) - Inc. revealed that PathogenDx ("PathogenDx" or "Company"), a leader in world-class microarray technology to advance molecular testing in human diagnostics, food and agricultural industries, placed No. 1232 on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list takes a one-of-a-kind look at the most successful companies within the economy's most dynamic segment-its...
2022-08-16 7:00 AM EDT
PathogenDx Awarded Honorable Mention in the Pandemic Response Category of Fast Company's 2022 World Changing Ideas Awards
Scottsdale, Arizona--(Newsfile Corp. - May 3, 2022) - PathogenDx ("PathogenDx" or "Company"), a U.S.-based biotechnology company setting the standard in molecular-based testing through the widespread adoption of its advanced microarray testing platform for the human diagnostics, food and agricultural industries, announced that it has been awarded an honorable mention in Fast Company's 2022 World Changing Ideas Awards in the "Pandemic Response" category for its introduction of a new,...
2022-05-03 8:00 AM EDT
PathogenDx's Receives Industry-First AOAC Certification to Detect Bacterial and Fungal Species in a Single Well Test for Cannabis Matrices
Multiplex Microbial Assay Accepted by a Regulatory Agency Scottsdale, Arizona--(Newsfile Corp. - April 19, 2022) - PathogenDx ("PathogenDx" or "Company"), a U.S.-based biotechnology company setting the standard in molecular-based testing through widespread adoption of...
2022-04-19 1:05 PM EDT
With a Two-Year Revenue Growth of 252 Percent, PathogenDx Ranks No. 46 on Inc. Magazine's List of the Southwest Region's Fastest-Growing Private Companies
Scottsdale, Arizona--(Newsfile Corp. - March 15, 2022) - Inc. magazine revealed that PathogenDx, a U.S.-based biotechnology company that is setting a new standard in molecular testing through widespread adoption of its advanced microarray testing platform for the human diagnostics, food and agricultural industries, is No. 46 on its third annual Inc. 5000 Regionals Southwest list, the most prestigious ranking of the fastest-growing private companies based in Arizona, New Mexico, Oklahoma and...
2022-03-15 8:30 AM EDT
BioTech Company PathogenDx Strengthens Executive Team; Announces Several New Key Leadership Appointments
Scottsdale, Arizona--(Newsfile Corp. - March 3, 2022) - PathogenDx, a U.S.-based biotechnology company, has bolstered its strategic advisory group and senior leadership team with the appointments of several highly experienced executives who will bring their expertise to the company as it sets a new global standard in molecular-based testing through the widespread adoption of its advanced microarray testing platform for the clinical & human diagnostics, food & agricultural and climate change...
2022-03-03 8:00 AM EST
Arizona Companies PathogenDx, Formula Diagnostics and Bashas' Food City Offer Safe, Accurate and Fast COVID-19 Testing to Uninsured Arizonans
Scottsdale, Arizona--(Newsfile Corp. - February 15, 2022) - PathogenDx, a biotechnology company setting the standard in molecular testing, Formula Diagnostics ("FDX"), a provider of clinical laboratories and health services, and Bashas' Food City, a family-owned-and-operated grocer, announced a community service partnership, which is bringing uninsured individuals in Phoenix and Mesa access to COVID-19 testing at no cost. The Arizona-based companies will be dedicating time and volunteering...
2022-02-15 7:00 AM EST
PathogenDx Announces the CE Marking of Its Next-Generation COVID-19 Testing Technology for the Simultaneous Detection of SARS-CoV-2 (COVID-19) and Its Variants
Scottsdale, Arizona--(Newsfile Corp. - February 2, 2022) - PathogenDx, a U.S.-based biotechnology company that is setting the standard in molecular testing through the widespread adoption of its innovative DNA microarray testing platform for the human diagnostics, food and agricultural industries, announced that its next-generation COVID-19 test technology, the Detectx-Cv+ test, has been CE marked in accordance with the requirements of the European Parliament and Council Directive 98/79/EC on...
2022-02-02 6:00 AM EST
PathogenDx annonce le marquage CE de sa technologie de test COVID-19 de nouvelle génération pour la détection simultanée du SARS-CoV-2 (COVID-19) et de ses variants
Scottsdale, Arizona--(Newsfile Corp. - 2 février 2022) - PathogenDx, une société de biotechnologie américaine qui établit la norme en matière de tests moléculaires grâce à l'adoption généralisée de sa plateforme innovante de tests par microsondes à ADN pour le diagnostic humain et les industries alimentaire et agricole, a annoncé que sa technologie de test COVID-19 de nouvelle génération, Detectx-Cv+, a été marqué CE conformément aux e
2022-02-02 2:00 AM EST